News
FDA knocks back AstraZeneca's self-injected lupus drug
FDA has delivered a setback to AstraZeneca by rebuffing its new formulation of lupus therapy Saphnelo, which was approved in Europe last year.
News
UK will cover transport costs for children with cancer
Families of young people with cancer in England will have the costs of travelling to medical appointments covered under a new funding scheme.
Oncology
Improving breast cancer outcomes in sub-Saharan Africa
New funding from The Pfizer Foundation will support breast cancer efforts in Kenya by the Academic Model Providing Access to Healthcare (AMPATH).
News
FDA starts review of Summit's VEGFxPD-1 bispecific
Summit moves ahead in the race to bring a VEGFxPD-(L)1 drug to market, after the FDA started a review of ivonescimab in lung cancer.
News
Eikon prices its IPO, seeking to raise $318m
Roger Perlmutter's new cancer biotech Eikon has priced its IPO, looking to raise up to $318m and achieve a $900m-plus valuation.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
